DK0882030T3 - 2,1,3-benzothia(oxa)diazolderivater med endothelinreceptor-antagonistisk virkning - Google Patents

2,1,3-benzothia(oxa)diazolderivater med endothelinreceptor-antagonistisk virkning

Info

Publication number
DK0882030T3
DK0882030T3 DK97905065T DK97905065T DK0882030T3 DK 0882030 T3 DK0882030 T3 DK 0882030T3 DK 97905065 T DK97905065 T DK 97905065T DK 97905065 T DK97905065 T DK 97905065T DK 0882030 T3 DK0882030 T3 DK 0882030T3
Authority
DK
Denmark
Prior art keywords
benzothia
oxa
endothelin receptor
antagonistic effect
receptor antagonistic
Prior art date
Application number
DK97905065T
Other languages
English (en)
Inventor
Dieter Dorsch
Mathias Osswald
Werner Mederski
Claudia Wilm
Claus Schmitges
Maria Christadler
Soheila Anzali
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0882030T3 publication Critical patent/DK0882030T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97905065T 1996-02-24 1997-02-20 2,1,3-benzothia(oxa)diazolderivater med endothelinreceptor-antagonistisk virkning DK0882030T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19607096A DE19607096A1 (de) 1996-02-24 1996-02-24 Endothelin-Rezeptor-Antagonisten
PCT/EP1997/000818 WO1997030982A1 (de) 1996-02-24 1997-02-20 2,1,3-benzothia(oxa)diazolderivate mit endothelinrezeptor-antagonistischer wirkung

Publications (1)

Publication Number Publication Date
DK0882030T3 true DK0882030T3 (da) 2002-01-07

Family

ID=7786418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97905065T DK0882030T3 (da) 1996-02-24 1997-02-20 2,1,3-benzothia(oxa)diazolderivater med endothelinreceptor-antagonistisk virkning

Country Status (14)

Country Link
US (1) US6017939A (da)
EP (1) EP0882030B1 (da)
CN (1) CN1072660C (da)
AR (1) AR005947A1 (da)
AT (1) ATE205486T1 (da)
AU (1) AU721203B2 (da)
DE (2) DE19607096A1 (da)
DK (1) DK0882030T3 (da)
ES (1) ES2164328T3 (da)
PT (1) PT882030E (da)
RU (1) RU2175320C2 (da)
UA (1) UA51696C2 (da)
WO (1) WO1997030982A1 (da)
ZA (1) ZA971466B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653037A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19710831A1 (de) * 1997-03-15 1998-09-17 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19712141A1 (de) * 1997-03-22 1998-09-24 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714391A1 (en) * 1993-08-19 1996-06-05 Warner-Lambert Company Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists
DE19509950A1 (de) * 1995-03-18 1996-09-19 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
EP0882030B1 (de) 2001-09-12
CN1216540A (zh) 1999-05-12
UA51696C2 (uk) 2002-12-16
AR005947A1 (es) 1999-07-21
ZA971466B (en) 1997-08-28
DE19607096A1 (de) 1997-08-28
RU2175320C2 (ru) 2001-10-27
AU1875797A (en) 1997-09-10
EP0882030A1 (de) 1998-12-09
AU721203B2 (en) 2000-06-29
ES2164328T3 (es) 2002-02-16
PT882030E (pt) 2002-03-28
ATE205486T1 (de) 2001-09-15
DE59704603D1 (de) 2001-10-18
CN1072660C (zh) 2001-10-10
WO1997030982A1 (de) 1997-08-28
US6017939A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
ATE226212T1 (de) 2-(purin-9-)-tetrahydrofuran-3,4-diol-derivate
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO20011183D0 (no) 4,4-biarylpiperidinderivater med opoid reseptoraktivitet
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
HUP0102470A3 (en) 1,3-azole derivatives as retinoid-associated receptor regulators and their use
ZA959268B (en) [3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy]-pyridine, pyrimidine and benzene derivatives as alpha1-adreno-ceptor antagonists.
ATE266630T1 (de) Benzamidinderivate mit ltb4- antagonistischer wirkung
DK1027361T3 (da) Derivater af erythromycin med 6,11-bro
DE69704701T2 (de) Muskarinrezeptor antagonistische oxa- und thiadiazole
ATE227282T1 (de) 2,4-diaminopyrimidin-derivate
BR9507220A (pt) Antagonistas de receptores de endotelina
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
NO20003825L (no) 1,3,4 - oxadiazolonderivater
ZA9811490B (en) Herbicidal 3-(benzazol-4-yl)pyrimidinedione derivatives.
DK0882030T3 (da) 2,1,3-benzothia(oxa)diazolderivater med endothelinreceptor-antagonistisk virkning
DE69714358T2 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
DE69929354D1 (de) 2,4-disubstierte triazinderivate mit anti-hiv aktivität
SI0882030T1 (en) 2,1,3-benzothia(oxa)diazole derivatives having an endothelin receptor antagonistic effect
NO20000324D0 (no) Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister
AU1875697A (en) N-(2,1,3-benzothia(oxa)diazolyl)-sulphonamides having an endothelin receptor antagonistic effect
DE69815072D1 (de) Substituierte 2,4-diaminopyrimidine
AU5663598A (en) 2,1,3-benzothia(oxa)diazole derivatives and their use as endothelin-receptor antagonists